FULGENT GENETICS, INC. Disposal Group, Including Discontinued Operation, Operating Income (Loss)
FULGENT GENETICS, INC. (FLGT) reported Disposal Group, Including Discontinued Operation, Operating Income (Loss) of -$359.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss · last filed 2018-03-20
- FULGENT GENETICS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2016-12-31 was $0.00.
- FULGENT GENETICS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2016-09-30 was $0.00.
- FULGENT GENETICS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2016-06-30 was -$18.00K.
- FULGENT GENETICS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2016-03-31 was -$341.00K.
- FULGENT GENETICS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2016 was -$359.00K.
- FULGENT GENETICS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2015 was -$3.33M.
- FULGENT GENETICS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2014 was -$3.29M.
| Period end | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 3 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 6 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 9 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $0.00 derived: sum of 2 quarters · filed 2018-03-20 | -$18.00K derived: sum of 3 quarters · filed 2018-03-20 | -$359.00K 10-K · filed 2018-03-20 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$18.00K derived: sum of 2 quarters · filed 2017-11-13 | -$359.00K 10-Q · filed 2017-11-13 | -$1.57M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | -$18.00K 10-Q · filed 2017-08-14 | -$359.00K 10-Q · filed 2017-08-14 | -$1.57M derived: sum of 3 quarters · filed 2017-08-14 | -$2.39M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$341.00K 10-Q · filed 2017-05-09 | -$1.55M derived: sum of 2 quarters · filed 2017-05-09 | -$2.37M derived: sum of 3 quarters · filed 2017-05-09 | |
| 2015-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$2.03M derived: sum of 2 quarters · filed 2017-03-17 | -$3.33M 10-K · filed 2017-03-17 | |
| 2015-09-30 | -$821.00K 10-Q · filed 2016-11-14 | -$2.12M 10-Q · filed 2016-11-14 | ||
| 2014-12-31 | -$3.29M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |